Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Pediatric Migraine and Genetic Culprits
• Obesity Promotes the Accumulation of Proinflammatory Proteins
• Gene Variant Seen in Cases of Severe Scoliosis
• Stopping OA in its Tracks?
• Engaging Alternative Therapies--Insurers Aren't Helping
• Crohn's Disease: Better Prediction = Better Treatment
• Comorbidities, Including Pain, from Hip Arthroscopy are Common
• Genetic Variants Implicated in Chronic Back Pain
• More Coffee=Less Pain
• The Crisis of Misuse and Abuse: Bigger and Longer Than Opioids